Aparna Biosciences Corporation

Rockville, MD 20852

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.44MM
First Award Date 09/16/08
Most Recent Award Date 09/01/09

Key Personnel

Last Name Name Awards Contact
Woodle Martin C Woodle 4
Scaria Puthupparampil V Scaria 1

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-009
Budget: 09/01/09 - 08/31/11

DESCRIPTION (provided by applicant): Development of rationally designed vaccines is an important need that nanotechnology has tremendous potential to transform. Already nanoparticle developments are incorporated into approved small molecule therapeutics. Advances are making rapid progress toward ligand targeted nanoparticles exhibiting tissue se...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-009
Budget: 09/01/09 - 08/31/11

DESCRIPTION (provided by applicant): In spite of recent advances, cancer remains a major killer posing a dire need for more effective therapy, and unfortunately this is particularly true for metastatic non-small cell lung cancer (NSCLC), which afflicts an extremely large number of patients and is one of the least treatable cancers. With the grow...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-009
Budget: 09/01/09 - 08/31/11

DESCRIPTION (provided by applicant): A need for better gene delivery has blocked the potential advancement in biomedical research and most critically development of better therapeutics that operate at the gene function level. This problem is most acute for non-dividing cells, which in fact are the predominant cell type. Thus the considerable int...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/30/08 - 08/31/09

DESCRIPTION (provided by applicant): A need for better gene delivery has blocked the potential advancement in biomedical research and most critically development of better therapeutics that operate at the gene function level. This problem is most acute for non-dividing cells, which in fact are the predominant cell type. Thus the considerable int...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/16/08 - 08/31/09

DESCRIPTION (provided by applicant): In spite of recent advances, cancer remains a major killer posing a dire need for more effective therapy, and unfortunately this is particularly true for metastatic non-small cell lung cancer (NSCLC), which afflicts an extremely large number of patients and is one of the least treatable cancers. With the grow...